You are here

J&J drug unit to leverage Singapore's biotech hub

'Very lively biotech hub' spurs pharmaceutical arm's external collaborations

Group chairman Ong Ai Hua says Janssen Asia Pacific's focus in Singapore is more on innovation than manufacturing.


JOHNSON & Johnson's (J&J) regional pharmaceutical head believes that Singapore offers innovation, research and development tie-up opportunities, even as wider insurance coverage in the Asia-Pacific is expected to fuel growth for drugmakers.

Ong Ai Hua, the group...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to